Global Precision Oncology Supply, Demand and Key Producers, 2023-2029

Global Precision Oncology Supply, Demand and Key Producers, 2023-2029

The global Precision Oncology market size is expected to reach $ 184270 million by 2029, rising at a market growth of 9.4% CAGR during the forecast period (2023-2029).

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

This report studies the global Precision Oncology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Precision Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Precision Oncology that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Precision Oncology total market, 2018-2029, (USD Million)

Global Precision Oncology total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Precision Oncology total market, key domestic companies and share, (USD Million)

Global Precision Oncology revenue by player and market share 2018-2023, (USD Million)

Global Precision Oncology total market by Type, CAGR, 2018-2029, (USD Million)

Global Precision Oncology total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Precision Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America, QIAGEN, Rain Oncology and Relay Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Precision Oncology market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Precision Oncology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Precision Oncology Market, Segmentation by Type
Diagnostics
Therapeutics

Global Precision Oncology Market, Segmentation by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies

Companies Profiled:
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.

Key Questions Answered

1. How big is the global Precision Oncology market?

2. What is the demand of the global Precision Oncology market?

3. What is the year over year growth of the global Precision Oncology market?

4. What is the total value of the global Precision Oncology market?

5. Who are the major players in the global Precision Oncology market?

6. What are the growth factors driving the market demand?